Compare CULP & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CULP | XTNT |
|---|---|---|
| Founded | 1972 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Textiles | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.2M | 39.6M |
| IPO Year | 1994 | 2009 |
| Metric | CULP | XTNT |
|---|---|---|
| Price | $3.47 | $0.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $1.03 |
| AVG Volume (30 Days) | 40.9K | ★ 147.0K |
| Earning Date | 12-09-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 47.06 | ★ 125.00 |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $203,482,000.00 | $53,337,000.00 |
| Revenue This Year | $3.15 | N/A |
| Revenue Next Year | $1.77 | $10.85 |
| P/E Ratio | $7.47 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.70 | $0.27 |
| 52 Week High | $4.17 | $0.84 |
| Indicator | CULP | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 43.36 | 35.92 |
| Support Level | $3.46 | N/A |
| Resistance Level | $3.48 | $0.33 |
| Average True Range (ATR) | 0.17 | 0.03 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 37.41 | 9.29 |
Culp Inc manufactures, sources, and markets mattress fabrics, sewn covers for mattresses, foundations, and other bedding products, and upholstery fabrics, including cut and sewn kits, for residential, commercial, and hospitality furniture and other applications. It markets fabrics produced at its manufacturing facilities and fabrics sourced through other suppliers to bedding and furniture companies. Its products serve the bedding, residential furnishings, commercial furnishings, and hospitality furnishings markets. Its segments are: Bedding and Upholstery, with Bedding generating the maximum revenue. The Bedding segment supplies the bedding market, comprising mattress sets and bedding accessory products. It generates the maximum revenue from the United States.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.